{"pageContent": "Purpose of review: Quality of life (QoL) outcomes have been reported in the literature and incorporated in decision-making in localized prostate cancer management for decades. Until recently, there was less emphasis on understanding the QoL effects of therapies for patients with advanced disease, possibly because there were fewer options for treatment. The purpose of this review is to summarize the key recent literature describing QoL outcomes for prostate cancer treatments in different disease settings.", "metaData": {"source": "Glycans as Biomarkers in Prostate Cancer\nhttps://pubmed.ncbi.nlm.nih.gov/30893936/"}}